Adderall® (amphetamine-dextroamphetamine) toxicity.

@article{Fitzgerald2013AdderallT,
  title={Adderall® (amphetamine-dextroamphetamine) toxicity.},
  author={Kevin T Fitzgerald and Alvin Bronstein},
  journal={Topics in companion animal medicine},
  year={2013},
  volume={28 1},
  pages={2-7}
}
The American Psychiatric Association estimates that 3-7% of US school-aged children exhibit attention-deficit/hyperactivity disorder (ADHD). Adderall(®) (amphetamine dextroamphetamine) and a variety of brand names and generic versions of this combination are available by prescription to treat ADHD and narcolepsy. Both immediate and sustained release products are used as are single agent amphetamine medication. Knowing the exact agent ingested can provide information of dose labeled and length… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Long - term stimulant medication treatment of ADHD : results from a population - based study

WJ Barbaresi, SK Katusic, RC Colligan
J Dev Behav Pediatr • 2006

Myocardial infarction in an adolescent taking Adderall.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2005

Similar Papers

Loading similar papers…